(Updated - March 2, 2021 6:53 AM EST)

Jefferies analyst Michael Yee downgraded FibroGen (NASDAQ: FGEN) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE